Clinical Trials Browser

INDUSTRY × Resectable Colon Cancer × Capecitabine × Clear all

NCT07412613 2026-02-27

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Phase 3 Not yet recruiting

GastrointestinalOther solid neoplasm

Resectable Colon Cancer